J.P. Morgan Healthcare Conference

JPM26 Live Blog Day 2: GSK Stays the Course Amid Key Biopharma Updates

2 weeks ago talkbio0Tagged AstraZeneca, Day 2, J.P. Morgan Healthcare Conference, JPM26, Nordisk, SmithKline Beecham

JPM26; GSK; J.P. Morgan Healthcare Conference; Day 2; AstraZeneca; Novo Nordisk; biotech

JPM26 Day 1 Live Blog: Slow Deal Flow Amid Optimism at J.P. Morgan Healthcare Conference

2 weeks ago talkbio0Tagged AI healthcare, Flow, J.P. Morgan Healthcare Conference, JPM26, M&A

JPM26; J.P. Morgan Healthcare Conference; deal flow; AI healthcare; biotech; M&A

Speculation builds about a multibillion-dollar takeout of Revolution Medicines

2 weeks ago talkbio0Tagged AbbVie, Acquisition, daraxonrasib, financial, J.P. Morgan Healthcare Conference, Merck, Neoplasms, RAS-driven cancers, Revolution Medicines, rumors, RVMD, takeover talks, Wall Street Journal

Revolution Medicines; RVMD; Merck; AbbVie; takeover talks; acquisition rumors; buyout speculation; Financial Times report; Wall Street Journal; J.P. Morgan Healthcare Conference; multibillion-dollar deal; oncology; RAS-driven cancers; daraxonrasib

From JP Morgan to the Next Wave: What’s Driving Biotech in 2026

3 months ago talkbio0Tagged 2026, Artificial Intelligence, Drug Discovery, Hematology (discipline), Investments, J.P. Morgan Healthcare Conference, M&A activity, Neoplasms, Neuropsychology, regulatory science, trends qualifier

J.P. Morgan Healthcare Conference; biotech trends 2026; M&A activity; oncology; neuropsychology; hematology; artificial intelligence; drug discovery; investment; regulatory science